SEC Form D filing

Cellanome, Inc.

Biotech · Growth · Regulation D 506(b) · CA · Filed June 22, 2026

Offering amount: $75.9M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: June 22, 2026
Signature date: June 18, 2026
CIK: 0001886462

Summary

Auto-generated

The issuer's name suggests a biotechnology company focused on cellular or genomic technologies. This California-based entity filed a Rule 506(b) disclosure on June 22, 2026, for a $75,930,476 offering.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.